The mission of ARTEMIS ONE HEALTH:
Our mission is to make a DIFFERENCE in the lives of humans and animals by performing innovative and translational research, with the ultimate goal to develop SAFE, EFFECTIVE and AFFORDABLE vaccines against neglected infectious diseases.
RESEARCH
Artemis focuses on virus infections with a major impact on society, with the area of neglected viral disease as an important area of focus. More than one billion people living in developing countries are at risk of infection with arboviral or zoonotic viral diseases. The research domains of Artemis are divided into three inter-related, partly overlapping core areas: studies on the ECOLOGY of virus infections, the understanding of PATHOGENESIS and development of effective INTERVENTION STRATEGIES. A multidisciplinary and integrated approach is pursued in this overlap.
Artemis One Health initiates and participates in top-tier international fundamental and applied research projects within international research consortia, devoted to unraveling mechanisms of pathogenesis, disease ecology and pathogen evolution. This will facilitate the rational and evidence-based development of new generations of intervention strategies in the never-ending battle against infectious diseases
RESEARCH DOMAIN
Virus ecology Pathogenesis Intervention strategies
OUR VALUES
Commitment Innovation Reliable Partnership
OUR KEY FOCUS
Zoonotic Arboviruses Valorization Animal
HOW CAN YOU HELP?
Become an ambassador Donate Volunteer Partnership
RESEARCH FUNDING
Grants Private funding Public funding
PROJECTS
RESEARCH FOCUS
ZOONOTIC
Zoonotic virus infections place a huge burden on society in terms of disease burden and mortality, and …> VIEW VIDEO
ARBOVIRUS
More than one billion people living in the world’s poorest countries suffer from at least one neglected tropical disease, which can cause significant emotional distress, morbidity and mortality… > VIEW VIDEO
VALORIZATION
“Health systems in many disease endemic countries are noticeably weak. Patients either cannot afford or do not have access to adequate drugs, while human and other resources are overburdened by the volume of needs… > VIEW VIDEO
ANIMAL
Viruses also pose a threat to livestock and wildlife, thereby affecting the economy and endangering public health. Understanding viral diseases in domestic animals and wildlife is essential… > VIEW VIDEO
RESEARCH FUNDING STREAMS
Grants Private funding Public funding
RESEARCH FUNDING
GRANTS
Artemis is involved in several European funded projects. Within these projects Artemis is collaborating with the best scientists in the world, with the aim to study the mechanisms by which the respective viruses are cause disease and to develop vaccines against these diseases.
PRIVATE FUNDING & PUBLIC FUNDING
External funding is the primary source of money for various projects and programs. This funding allows ARTEMIS to carry out its objectives more adequately and to expand and enhance the variety of opportunities available in ARTEMIS.
RESEARCH PROJECTS
The following viruses are being studied currently, embedded in several projects.
COMPARE
<< ZOONOTIC>>
Compare is a consortium consisting of various institutions from different EU countries and subsidized by the European Commission. This consortium is working to develop a platform that allows rapid identification of new infectious diseases… > LEARN MORE
ZAPI
<< ZOONOTIC >>
Zapi is an EC subsidized consortium consisting of several public and private institutions. This consortium aims at developing a platform that allows rapid identification of new viral diseases and rapid development of vaccines against these newly emerging viruses… > LEARN MORE
FLUCOP
<< ZOONOTIC >>
Flucop is a consortium of public and private partners that work together to define the part of the immune system that is most important in providing protection against influenza virus… > LEARN MORE
FLUNIVAC
<< ZOONOTIC >>
Flunivac is an EC subsidized consortium consisting of several public and private institutions. The aim of this consortium is to develop an universal vaccine against influenza virus, which would eliminate the need to change the composition of the vaccine every year… > LEARN MORE
YELLOW FEVER
<< ARBOVIRUS >>
Yellow fever virus has the potential to cause big (urban) epidemics as exemplified by the situation before 1950s. However, the majority of the reported outbreaks to date are mainly seen in Africa and South America and have a forest (sylvatic) origin… > LEARN MORE
ECOALERT
<< ARBOVIRUS >>
Arbovirus outbreaks are widespread, unexplained and unpredictable. This makes current surveillance approaches focusing on Arbovirusesindividual diseases and exotic vector populations inadequate, financially unsustainable, and unsatisfying for decision making by public health officials in early stages of emergence… > LEARN MORE
DENGUE
<< ARBOVIRUS >>
Dengue virus (DENV) infection is a huge and growing problem in tropical and subtropical areas of the world. Approximately 390 million people are infected annually worldwide with DENV, which may develop into severe disease, characterized by shock and multi-organ failure (MOF), especially in children… > LEARN MORE
CHIKUNGUNYA
<< ARBOVIRUS >>
Chikungunya virus (CHIKV) is transmitted to people by mosquitoes, the same mosquitoes that transmit dengue and Zika. Historically distributed across tropical Africa and Southeast Asia, CHIKV has in recent years expanded its geographical range across the Indian Ocean and lately across South America and the Caribbean… > LEARN MORE
TBEV-COMEIN
<< ARBOVIRUS >>
Ticks are able to transmit a wide range of diseases to both humans and animals, including Lyme’s disease and tick-borne encephalitis (TBE). TBE, a disease caused by the tick-borne encephalitis virus (TBEV), is often associated with neurological symptoms in humans… > LEARN MORE
RABIES
<< VALORIZATION >>
Rabies virus (RABV), a member of the Lyssavirus genus is transmitted by the bite or scratches of infected animals (primarily dogs but also by cats, wildlife and bats), causes rabies encephalitis and accounts for more than 55,000 reported fatal human cases each year… > LEARN MORE
INFLUENZA
<< VALORIZATION >>
A universal influenza vaccine is one of the largest unmet medical needs. Yearly 250,000 to 500,000 people die from seasonal influenza, and on average 3 to 5 million hospitalizations occur each year… > LEARN MORE
ELEPHANT HERPESVIRUS
<< ANIMAL >>
The high mortality rates associated with elephant herpesvirus (EEHV) infections in captive and wild elephants and the threat they pose to the continuation and success of captive breeding programs for the highly endangered Asian elephant in both North America and Europe, makes the development of a safe and effective vaccine a high priority. .. > LEARN MORE
PARTNER WITH US
We would be very happy to establish a partnership with you, as we see it beneficial for both parties. If you are interested in working with us, contact:
Dr. Byron Martina – Head Research & Development of Artemis One Health Research Foundation
E-mail: b.martina@artemisonehealth.com
Office phone: +31 (0)30 635 5444
Or feel free to FILL IN our PARTNERSHIP CONTACT FORM. We will respond to you within 48 hours.
CONTRIBUTE TO HEALTH OF SELF AND OTHERS!
MAKE A DIFFERENCE, AND COME INTO ACTION
Be our supporter!
Donate TODAY to a specific cause!
-
Zika threatens more than just the unborn developing baby
"Zika", a threat to children, a threat to the economy.€5,00 donated of €60.000,00 goal -
Rabies treatment for “ALL”
"IMAGINE", a future where rabies is treatable.€815,00 donated of €60.000,00 goal
Let’s get in touch
FOLLOW US ON: